BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34594110)

  • 1. microRNA-564 Inhibits the Aggressive Phenotypes of Papillary Thyroid Cancer by Directly Targeting Astrocyte-Elevated Gene-1 [Retraction].
    Onco Targets Ther; 2021; 14():4897-4898. PubMed ID: 34594110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-937 Inhibits the Malignant Phenotypes of Breast Cancer by Directly Targeting and Downregulating Forkhead Box Q1 [Retraction].
    Onco Targets Ther; 2021; 14():4991-4992. PubMed ID: 34675539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-675 Directly Targets MAPK1 to Suppress the Oncogenicity of Papillary Thyroid Cancer and is Sponged by Long Non-Coding RNA RMRP [Retraction].
    Onco Targets Ther; 2021; 14():4995-4996. PubMed ID: 34675540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-622 Suppresses Tumor Formation by Directly Targeting VEGFA in Papillary Thyroid Carcinoma [Retraction].
    Onco Targets Ther; 2021; 14():3597. PubMed ID: 34113125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-605 Inhibits the Oncogenicity of Non-Small-Cell Lung Cancer by Directly Targeting Forkhead Box P1 [Retraction].
    Onco Targets Ther; 2021; 14():4933-4934. PubMed ID: 34611411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-769 is Downregulated in Colorectal Cancer and Inhibits Cancer Progression by Directly Targeting Cyclin-Dependent Kinase 1 [Retraction].
    Onco Targets Ther; 2021; 14():4851-4852. PubMed ID: 34602822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-605 Directly Targets SOX9 to Alleviate the Aggressive Phenotypes of Glioblastoma Multiforme Cell Lines by Deactivating the PI3K/Akt Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4739-4740. PubMed ID: 34526778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-628 Inhibits the Proliferation of Acute Myeloid Leukemia Cells by Directly Targeting IGF-1R [Retraction].
    Onco Targets Ther; 2021; 14():4847-4848. PubMed ID: 34584423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-493 Inhibits Tongue Squamous Cell Carcinoma Oncogenicity via Directly Targeting HMGA2 [Retraction].
    Onco Targets Ther; 2021; 14():4737-4738. PubMed ID: 34526777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-769-5p Inhibits Pancreatic Ductal Adenocarcinoma Progression by Directly Targeting and Downregulating ETS Proto-Oncogene 1 [Retraction].
    Onco Targets Ther; 2021; 14():4965-4966. PubMed ID: 34629880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-564 inhibits the aggressive phenotypes of papillary thyroid cancer by directly targeting astrocyte-elevated gene-1.
    Song Z; Yang H; Wu X; Kong C; Xu C
    Onco Targets Ther; 2019; 12():4869-4881. PubMed ID: 31388302
    [No Abstract]   [Full Text] [Related]  

  • 12. microRNA-612 Suppresses the Malignant Development of Non-Small-Cell Lung Cancer by Directly Targeting Bromodomain-Containing Protein 4 [Retraction].
    Onco Targets Ther; 2021; 14():4745-4746. PubMed ID: 34526781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA DLGAP1-AS1 Promotes the Aggressive Behavior of Gastric Cancer by Acting as a ceRNA for microRNA-628-5p and Raising Astrocyte Elevated Gene 1 Expression [Retraction].
    Cancer Manag Res; 2021; 13():7495-7496. PubMed ID: 34611445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-212 Inhibits Hepatocellular Carcinoma Cell Proliferation and Induces Apoptosis by Targeting FOXA1 [Retraction].
    Onco Targets Ther; 2022; 15():849-850. PubMed ID: 35975009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA SNHG16 Drives Proliferation and Invasion of Papillary Thyroid Cancer Through Modulation of miR-497 [Retraction].
    Onco Targets Ther; 2021; 14():4747-4748. PubMed ID: 34526782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-559 Plays an Inhibitory Role in the Malignant Progression of Glioblastoma Cells by Directly Targeting Metadherin [Retraction].
    Onco Targets Ther; 2021; 14():4899-4900. PubMed ID: 34594111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-145 Inhibits the Activation of the mTOR Signaling Pathway to Suppress the Proliferation and Invasion of Invasive Pituitary Adenoma Cells by Targeting AKT3 in vivo and in vitro [Retraction].
    Onco Targets Ther; 2020; 13():6851. PubMed ID: 32764974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-145-5p Inhibits Gastric Cancer Invasiveness through Targeting N-Cadherin and ZEB2 to Suppress Epithelial-Mesenchymal Transition [Retraction].
    Onco Targets Ther; 2023; 16():751-752. PubMed ID: 37731628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA-548b Suppresses Aggressive Phenotypes of Hepatocellular Carcinoma by Directly Targeting High-Mobility Group Box 1 mRNA [Retraction].
    Cancer Manag Res; 2021; 13():7593-7594. PubMed ID: 34675654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression by Targeting PDK1/PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2023; 16():1023-1024. PubMed ID: 38090112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.